Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8770)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2015 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tsutsumi Y, Yamamoto Y, Ito S, Ohigashi H, Shiratori S, Naruse H, Teshima T. Hepatitis B virus reactivation with a rituximab-containing regimen. World J Hepatol 2015; 7(21): 2344-2351 [PMID: 26413224 DOI: 10.4254/wjh.v7.i21.2344] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i21/2344.htm |
| Number | Citing Articles |
| 1 |
Louis-Bassett Porter, Elena Kozakewich, Ryan Clouser, Colleen Kershaw, Andrew J. Hale. Occam’s razor need not apply: Advanced HIV infection presenting with five simultaneous opportunistic infections and central nervous system lymphoma. IDCases 2018; 13: e00437 doi: 10.1016/j.idcr.2018.e00437
|
| 2 |
Funda PEPEDİL TANRİKULU, Didar YANARDAĞ AÇIK, Bilal AYGUN, Mehmet BANKİR, Mikail ÖZDEMİR. The compliance of our practice of hepatitis B virus screening with the current guidelines in patients undergoing chemotherapy for hematological malignancies. Journal of Surgery and Medicine 2021; 5(11): 1095 doi: 10.28982/josam.981625
|
| 3 |
Takuhiro Shoji, Masayuki Kanamori, Jun Inoue, Ryuta Saito, Yoshinari Osada, Yoshiteru Shimoda, Masashi Chonan, Hiroshi Uenohara, Atsushi Masamune, Teiji Tominaga. Hepatitis B virus reactivation during temozolomide administration for malignant glioma. International Journal of Clinical Oncology 2021; 26(2): 305 doi: 10.1007/s10147-020-01814-7
|
| 4 |
R.N. Makroo, Soma Agrawal, Mohit Chowdhry, Brinda Kakkar, Uday K. Thakur. Efficacy of single, extended and goal directed immunoadsorption in ABO incompatible living related donor liver transplantation. Transfusion and Apheresis Science 2016; 55(3): 329 doi: 10.1016/j.transci.2016.08.007
|
| 5 |
|
| 6 |
Bertram Bengsch, Kyong-Mi Chang. Evolution in Our Understanding of Hepatitis B Virus Virology and Immunology. Clinics in Liver Disease 2016; 20(4): 629 doi: 10.1016/j.cld.2016.06.001
|
| 7 |
Michał Witkowski, Magdalena Witkowska, Tadeusz Robak. Autoimmune thrombocytopenia: Current treatment options in adults with a focus on novel drugs. European Journal of Haematology 2019; 103(6): 531 doi: 10.1111/ejh.13319
|
| 8 |
Tetsuya Akaishi, Ichiro Nakashima. Efficiency of antibody therapy in demyelinating diseases. International Immunology 2017; 29(7): 327 doi: 10.1093/intimm/dxx037
|
| 9 |
Ernesto Gargiulo, Rebecca Svanberg Teglgaard, Tereza Faitová, Carsten Utoft Niemann. Immune Dysfunction and Infection – Interaction between CLL and Treatment: A Reflection on Current Treatment Paradigms and Unmet Needs. Acta Haematologica 2024; 147(1): 84 doi: 10.1159/000533234
|
| 10 |
Timothy M. Block, Kyong-Mi Chang, Ju-Tao Guo. Prospects for the Global Elimination of Hepatitis B. Annual Review of Virology 2021; 8(1): 437 doi: 10.1146/annurev-virology-091919-062728
|
| 11 |
Praopilad Srisuwarn, Vasant Sumethkul. Kidney transplant from donors with hepatitis B: A challenging treatment option. World Journal of Hepatology 2021; 13(8): 853-867 doi: 10.4254/wjh.v13.i8.853
|
| 12 |
Sophia Ly, Dmitry Nedosekin, Henry K. Wong. Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin. American Journal of Clinical Dermatology 2023; 24(2): 247 doi: 10.1007/s40257-022-00751-7
|
| 13 |
Luis Malpica, David van Duin, Stephan Moll. Preventing infectious complications when treating non‐malignant immune‐mediated hematologic disorders. American Journal of Hematology 2019; 94(12): 1396 doi: 10.1002/ajh.25642
|
| 14 |
Hyun Mi Kwon, Kichul Shin, Jin Young Moon, Shin-Seok Lee, Won Tae Chung, Jisoo Lee, Sang-Heon Lee, Seong-Wook Kang, Chang Hee Suh, Seung-Jae Hong, Ran Song, Jung-Yoon Choe, Yeong Wook Song. Transaminase Changes in Korean Rheumatoid Arthritis Patients with Chronic Hepatitis C after Biologic Therapy. Journal of Rheumatic Diseases 2018; 25(2): 108 doi: 10.4078/jrd.2018.25.2.108
|
| 15 |
Béatrice Laupèze, Ventzislav Vassilev, Selim Badur. A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments. Expert Review of Gastroenterology & Hepatology 2023; 17(11): 1135 doi: 10.1080/17474124.2023.2268503
|
| 16 |
Chrong-Reen Wang, Hung-Wen Tsai. Human hepatitis viruses-associated cutaneous and systemic vasculitis. World Journal of Gastroenterology 2021; 27(1): 19-36 doi: 10.3748/wjg.v27.i1.19
|
| 17 |
Cesare Mazzaro, Riccardo Bomben, Marcella Visentini, Laura Gragnani, Luca Quartuccio, Francesco Saccardo, Marco Sebastiani, Davide Filippini, Gianfranco Lauletta, Giuseppe Monti, Valter Gattei. Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1095780
|
| 18 |
Daryl R Cheng, Rebecca Barton, Anthea Greenway, Nigel W Crawford. Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients. Expert Review of Vaccines 2016; 15(12): 1567 doi: 10.1080/14760584.2016.1193438
|
| 19 |
Maria Guarino, Marco Picardi, Anna Vitiello, Novella Pugliese, Matilde Rea, Valentina Cossiga, Fabrizio Pane, Nicola Caporaso, Filomena Morisco. Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma. Annals of Hepatology 2017; 16(2): 198 doi: 10.5604/16652681.1231579
|
| 20 |
Shigeru Kusumoto, Luca Arcaini, Xiaonan Hong, Jie Jin, Won Seog Kim, Yok Lam Kwong, Marion G. Peters, Yasuhito Tanaka, Andrew D. Zelenetz, Hiroshi Kuriki, Günter Fingerle-Rowson, Tina Nielsen, Eisuke Ueda, Hanna Piper-Lepoutre, Gila Sellam, Kensei Tobinai. Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy. Blood 2019; 133(2): 137 doi: 10.1182/blood-2018-04-848044
|
| 21 |
Daisuke Ueki, Shinya Suzuki, Takahiro Ohta, Akira Shinohara, Yasukata Ohashi, Daisuke Konuma, Yasuaki Ryushima, Ryoko Udagawa, Hironori Motoshige, Masahiro Ieoka, Akihiro Taji, Yuuki Kogure, Mikako Hiraike, Miyuki Uoi, Kazuhiko Ino, Toshikatsu Kawasaki, Masakazu Yamaguchi. Cancer-Chemotherapy-Related Regimen Checks Performed by Pharmacists of General Hospitals Other than Cancer Treatment Collaborative Base Hospitals: A Multicenter, Prospective Survey. Pharmacy 2023; 12(1): 1 doi: 10.3390/pharmacy12010001
|
| 22 |
Prowpanga Udompap, W. Ray Kim. Hepatitis B Virus and Liver Disease. 2021; : 427 doi: 10.1007/978-981-16-3615-8_18
|
| 23 |
Xiao Yan, Miao Zhou, Zhongze Lou, Qitian Mu, Lixia Sheng, Ping Zhang, Yi Wang, Guifang Ouyang. Diffuse large B-cell lymphoma with concurrent hepatitis B virus infection in the MabThera era. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 1): S248 doi: 10.4103/0973-1482.187285
|
| 24 |
Chunmei Yang, Mixue Xie, Kaifeng Zhang, Hui Liu, Aibin Liang, Ken H. Young, Wenbin Qian. Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection. Leukemia 2020; 34(11): 3055 doi: 10.1038/s41375-020-0913-y
|
| 25 |
Ai Kubodera, Ayaka Kume, Kiyohito Hayashi, Ryo Shimizu, Akihiro Miyakawa, Yoshihiro Miyauchi, Yoshio Suzuki, Hiroaki Tanaka. Immune Thrombocytopenic Purpura Complicated by Hepatitis C Virus-related Membranoproliferative Glomerulonephritis after Rituximab Therapy. Internal Medicine 2021; 60(15): 2469 doi: 10.2169/internalmedicine.6758-20
|
| 26 |
Jingjing Wang, Xin Zhang, Xiaozhen Geng, Juanjuan Shi, Xiaoli Jia, Shuangsuo Dang, Wenjun Wang. Risk of hepatitis B virus reactivation following treatment with abatacept: A retrospective study of international pharmacovigilance databases. eClinicalMedicine 2022; 48: 101425 doi: 10.1016/j.eclinm.2022.101425
|
| 27 |
Keaton R. Jones, Craig S. Lammert. Management of Autoimmune Hepatitis Patients Refractory to or Intolerant of Standard Therapies. Current Hepatology Reports 2018; 17(3): 166 doi: 10.1007/s11901-018-0401-2
|
| 28 |
Dae San Yoo, Jong Hoon Kim, Soo-Chan Kim. Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximab. JAAD Case Reports 2020; 6(2): 83 doi: 10.1016/j.jdcr.2019.10.017
|
| 29 |
Katharina Boden, Sabine Lobenstein, Beate Hermann, Gabriele Margos, Volker Fingerle. Borrelia miyamotoi–Associated Neuroborreliosis in Immunocompromised Person. Emerging Infectious Diseases 2016; 22(9): 1617 doi: 10.3201/eid2209.152034
|
| 30 |
Denise Yeo, Ihtimam Hossain, Soon Thye Lim, Mohamad Farid, Miriam Tao, Richard Quek, Tiffany Tang, Alexandre Chan. Management of hepatitis B reactivation in lymphoma patients on rituximab with past hepatitis B exposure: An observational study. Journal of Oncology Pharmacy Practice 2019; 25(5): 1042 doi: 10.1177/1078155218763039
|
| 31 |
Esma Bilajac, Lejla Mahmutović, Kenneth Lundstrom, Una Glamočlija, Jasmin Šutković, Abas Sezer, Altijana Hromić-Jahjefendić. Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis. Viruses 2022; 14(10): 2105 doi: 10.3390/v14102105
|
| 32 |
Timothy P.W. Jones, Matthew Buckland, Judith Breuer, David M. Lowe. Viral infection in primary antibody deficiency syndromes. Reviews in Medical Virology 2019; 29(4) doi: 10.1002/rmv.2049
|
| 33 |
Sama Anvari, Keith Tsoi. Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?. Journal of Clinical Medicine 2024; 13(2): 393 doi: 10.3390/jcm13020393
|
| 34 |
Michael Kriss, Matthew Burchill. HCV and nonhepatic malignancy: Is pre‐emptive direct‐acting antiviral therapy indicated prior to treatment?. Hepatology 2018; 67(1): 4 doi: 10.1002/hep.29414
|
| 35 |
Natasha Dubois Cauwelaert, Susan L. Baldwin, Mark T. Orr, Anthony L. Desbien, Emily Gage, Kimberly A. Hofmeyer, Rhea N. Coler. Antigen presentation by B cells guides programing of memory CD4+ T‐cell responses to a TLR4‐agonist containing vaccine in mice. European Journal of Immunology 2016; 46(12): 2719 doi: 10.1002/eji.201646399
|
| 36 |
Connor Prosty, Khaled Katergi, Alex Nguyen, Owen Dan Luo, Mark Sorin, Vladimir Cherniak, Michael Sebag, Koray Demir, Emily G. McDonald, Todd C. Lee, Matthew P. Cheng. Risk of infectious adverse events of venetoclax therapy for hematologic malignancies: a systematic review and meta-analysis of RCTs. Blood Advances 2024; 8(4): 857 doi: 10.1182/bloodadvances.2023011964
|
| 37 |
Saket Jhajharia, Fritz Lai, Heng Boon Low, Kiren Purushotorman, Bhuvaneshwari D/O Shunmuganathan, Conrad En Zuo Chan, Rachel Hammond, Hans-Jürgen Netter, Qingfeng Chen, Seng Gee Lim, Paul A. MacAry. Defining the specificity and function of a human neutralizing antibody for Hepatitis B virus. npj Vaccines 2022; 7(1) doi: 10.1038/s41541-022-00516-7
|
| 38 |
Christopher Hahn, Adrian Budhram, Katayoun Alikhani, Nasser AlOhaly, Grayson Beecher, Gregg Blevins, John Brooks, Robert Carruthers, Jacynthe Comtois, Juthaporn Cowan, Paula de Robles, Julien Hébert, Ronak K. Kapadia, Sarah Lapointe, Aaron Mackie, Warren Mason, Brienne McLane, Alexandra Muccilli, Ilia Poliakov, Penelope Smyth, Kimberly G. Williams, Christopher Uy, Jennifer A. McCombe. Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 2024; : 1 doi: 10.1017/cjn.2024.16
|
| 39 |
Bernd Lorenz Hartmann, Michèle Desiré Atzl. HIV-triggered lymphoma. memo - Magazine of European Medical Oncology 2019; 12(3): 230 doi: 10.1007/s12254-019-00518-7
|
| 40 |
Wenli Zhu, Yaling Zhang, Zhen Wang, Ying Fu, Yaping Yan. Monoclonal Antibody-Based Treatments for Neuromyelitis Optica Spectrum Disorders: From Bench to Bedside. Neuroscience Bulletin 2020; 36(10): 1213 doi: 10.1007/s12264-020-00525-3
|
| 41 |
Jia Wei, Xiaojian Zhu, Xia Mao, Liang Huang, Fankai Meng, Jianfeng Zhou. Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0790-y
|
| 42 |
Young Chang, Soung Won Jeong, Jae Young Jang. Hepatitis B Virus Reactivation Associated With Therapeutic Interventions. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.770124
|
| 43 |
Ping Li, Lili Zhou, Shiguang Ye, Wenjun Zhang, Junbang Wang, Xiaochen Tang, Jie Liu, Yangyang Xu, Wenbin Qian, Aibin Liang. Risk of HBV Reactivation in Patients With Resolved HBV Infection Receiving Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Without Antiviral Prophylaxis. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.638678
|
| 44 |
Violeta Molagic, Cristina Popescu, Catalin Tiliscan, Victoria Arama, Stefan Sorin Arama. Rapid loss of HBs antigen in patients with HBV reactivation and high level of transaminases during immunosuppressive therapy - case series. Revista Romana de Medicina de Laborator 2021; 29(1): 105 doi: 10.2478/rrlm-2020-0039
|
| 45 |
G. Azizi, V. Ziaee, M. Tavakol, T. Alinia, R. Yazdai, H. Mohammadi, H. Abolhassani, A. Aghamohammadi. Approach to the Management of Autoimmunity in Primary Immunodeficiency. Scandinavian Journal of Immunology 2017; 85(1): 13 doi: 10.1111/sji.12506
|
| 46 |
Prowpanga Udompap, W. Ray Kim. Hepatitis B Virus and Liver Disease. 2018; : 315 doi: 10.1007/978-981-10-4843-2_16
|
| 47 |
Daniel Sedhom, Melroy D’Souza, Elizabeth John, Vinod Rustgi. Viral Hepatitis and Acute Liver Failure. Clinics in Liver Disease 2018; 22(2): 289 doi: 10.1016/j.cld.2018.01.005
|
| 48 |
Alison Jee, Samantha Christine Sernoskie, Jack Uetrecht. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges. International Journal of Molecular Sciences 2021; 22(6): 2954 doi: 10.3390/ijms22062954
|
| 49 |
Connor Cole, Kyle Amber. Pemphigus for the Inpatient Dermatologist. Current Dermatology Reports 2022; 11(4): 221 doi: 10.1007/s13671-022-00369-2
|
| 50 |
Arshi Khanam, Joel V. Chua, Shyam Kottilil. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. International Journal of Molecular Sciences 2021; 22(11): 5497 doi: 10.3390/ijms22115497
|
| 51 |
Jacky C. L. Ho, Joyce W. Y. Mak, Terry C. F. Yip, Hong Man Lam, Tsz Yan Cheng, Tsz On Lam, Lai Shan Tam, Man Fai Law, Carmen K. M. Cheung, Siew C. Ng, Vincent W. S. Wong, Grace L. H. Wong. Risk of alanine aminotransferase flare in patients with previous hepatitis B virus exposure on biological modifier therapies—A population‐based study. Liver International 2023; 43(3): 588 doi: 10.1111/liv.15499
|
| 52 |
N. Blank, H.-M. Lorenz. Kryoglobulinämische Vaskulitiden. Zeitschrift für Rheumatologie 2016; 75(3): 303 doi: 10.1007/s00393-016-0076-4
|
| 53 |
Sirina Ekpanyapong, K. Rajender Reddy. Hepatitis B Virus Reactivation. Clinics in Liver Disease 2020; 24(3): 317 doi: 10.1016/j.cld.2020.04.002
|
| 54 |
Kilian Bock, Heiner Wedemeyer, Young-Seon Mederacke, Ingmar Mederacke. Elevated liver enzymes in a German tertiary-care hospital: Distribution, diagnostic steps and diagnosis groups. Zeitschrift für Gastroenterologie 2024; doi: 10.1055/a-2150-2077
|
| 55 |
Kentaro Sato, Hidemichi Imamura, Yu Watahiki, Hiromasa Hazama, Takeaki Hashimoto, Shinji Mukae, Hiromasa Ohhira. A Hepatitis B Virus Reactivation Case Potentially Triggered by the Onset of Diffuse Large B Cell Lymphoma. Internal Medicine 2023; 62(11): 1611 doi: 10.2169/internalmedicine.0420-22
|
| 56 |
Guilherme Diogo Silva, Vítor Falcão de Oliveira, Leonardo Oliveira Mendonça. Challenges and insights in immunization in patients with demyelinating diseases: a bench-to-bedside and evidence-based review. Arquivos de Neuro-Psiquiatria 2022; 80(5 suppl 1): 173 doi: 10.1590/0004-282x-anp-2022-s121
|
| 57 |
Martin Feuchtenberger, Arne Schäfer, Axel Philipp Nigg, Michael Rupert Kraus. Hepatitis B Serology in Patients with Rheumatic Diseases. The Open Rheumatology Journal 2016; 10(1): 39 doi: 10.2174/1874312901610010039
|
| 58 |
Prajjwol Luitel, Anup Ghimire, Devansh Upadhyay, Rajeev Ojha. Efficacy of monoclonal antibodies in neuromyelitis optica: An updated systematic review with meta‐analysis. Clinical and Experimental Neuroimmunology 2022; 13(4): 194 doi: 10.1111/cen3.12695
|